Filing Analysis
ArrowMark Financial Corp. announced a significant leadership transition effective June 30, 2026, involving the retirement of CFO Patrick Farrell and the resignation of President Dana Staggs.
🚩 Red Flags
- Simultaneous departure of both the President and the Chief Financial Officer (dual executive turnover).
- Resignation/Retirement of key officers can sometimes signal internal friction or shifts in strategic direction.
📋 Key Facts
- Patrick Farrell retired as Chief Financial Officer (CFO) effective June 30, 2026.
- Katherine Jones appointed as new CFO, effective June 30, 2026; she has been with the team since ArrowMark Partners assumed management in 2019.
- Dana Staggs resigned from her position as President of the Company, effective June 30, 2026.
- The new CFO, Katherine Jones, is not expected to receive compensation for her services.
ArrowMark Financial Corp. entered into a Dealer Manager Agreement to facilitate a rights offering of common stock. The offer allows record date shareholders to subscribe for up to 2,604,156 new shares at a ratio of one new share for every three rights held.
🚩 Red Flags
- Rights offering can lead to significant dilution for existing shareholders who do not participate.
📋 Key Facts
- Record Date: January 22, 2026
- Rights Ratio: 1 new Common Share for every 3 Rights held (1-for-3)
- Total Shares Offered: Up to 2,604,156 shares of common stock
- Dealer Manager: UBS Securities LLC and ArrowMark Asset Management, LLC
- Subscription Agent: Equiniti Trust Company, LLC
- Information Agent: EQ Fund Solutions, LLC
ArrowMark Financial Corp. entered into a securities purchase agreement to conduct a direct public offering of 673,249 shares of common stock at $22.28 per share. The transaction is expected to raise approximately $15 million in gross proceeds.
🚩 Red Flags
- Direct public offering (DPO) can sometimes imply difficulty in accessing traditional capital markets, though common for closed-end investment companies.
📋 Key Facts
- Offering size: 673,249 shares of Common Stock
- Offering price: $22.28 per share
- Gross proceeds: Approximately $14,999,987.72 (exclusive of expenses)
- Transaction date: December 18, 2025
- Expected delivery date: December 19, 2025
- The offering was conducted under a previously effective Form N-2/A registration statement.
ArrowMark Financial Corp. entered into a distribution agreement with ALPS Distributors, Inc. to facilitate the 'at-the-market' (ATM) issuance and sale of up to $25,000,000 of its common stock.
🚩 Red Flags
- Potential for significant shareholder dilution through the ATM offering.
📋 Key Facts
- Entered into a Distribution Agreement with ALPS Distributors, Inc. on December 15, 2025.
- The offering is an 'at-the-market' (ATM) program under Rule 415.
- Maximum aggregate sale amount is $25,000,000 of common stock.
- UBS Securities LLC has been engaged as a sub-placement agent via a Sub-Placement Agent Agreement dated December 15, 2025.
ArrowMark Financial Corp. is currently non-compliant with Nasdaq's audit committee composition requirements following the death of independent director Michael Stolper on March 21, 2025. The company has been granted a cure period to appoint a replacement and regain compliance.
🚩 Red Flags
- Delisting notice/Non-compliance with Nasdaq listing rules.
- Potential for trading suspension if a replacement director is not appointed by the September 17, 2025 deadline (if applicable).
📋 Key Facts
- Death of independent director and Audit Committee member Michael Stolper occurred on March 21, 2025.
- The Company currently lacks the required three independent directors for its Audit Committee per Nasdaq Listing Rule 5605(c).
- Nasdaq has provided a cure period ending either at the next annual shareholders' meeting or September 17, 2025 (whichever is earlier/relevant based on specific conditions).
- The Nominating and Governance Committee is actively seeking a suitable independent candidate.